<!DOCTYPE html><html lang="en">
<head>
<title>SampleBaseline &lt; CTSpedia &lt; Foswiki</title>
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
<meta charset="utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1.5, user-scalable=yes" />
<meta name="mobile-web-app-capable" content="yes" />
<meta name="mobile-web-app-status-bar-style" content="black-translucent" />
<meta name="apple-mobile-web-app-capable" content="yes" />
<meta name="apple-mobile-web-app-status-bar-style" content="black-translucent" />
<link type="image/x-icon" href="../MISSING RESOURCE CTSpedia/SampleBaseline/favicon.ico" rel="icon"> <link href="../MISSING RESOURCE CTSpedia/SampleBaseline/favicon.ico" rel="shortcut icon" type="image/x-icon">
<link type="application/x-wiki" href="SampleBaseline.html" rel="alternate" title="edit SampleBaseline">
<meta name="description" content="SampleBaseline" />
<link href="../System/SmiliesPlugin.attachments/smilies.css" rel="stylesheet" media="all" class="head SMILIESPLUGIN" type="text/css"><!--SMILIESPLUGIN-->
<style class='head TABLEPLUGIN_default' type="text/css" media="all">
body .foswikiTable {border-width:1px}
body .foswikiTable .tableSortIcon img {padding-left:.3em; vertical-align:text-bottom}
body .foswikiTable td {border-style:solid none; vertical-align:top}
body .foswikiTable th {border-style:none solid; vertical-align:top; background-color:#d6d3cf; color:#000000}
body .foswikiTable th a:link {color:#000000}
body .foswikiTable th a:visited {color:#000000}
body .foswikiTable th a:hover {color:#000000; background-color:#d6d3cf}
body .foswikiTable th.foswikiSortedCol {background-color:#c4c1ba}
body .foswikiTable tr.foswikiTableRowdataBg0 td {background-color:#ffffff}
body .foswikiTable tr.foswikiTableRowdataBg0 td.foswikiSortedCol {background-color:#f7f7f6}
body .foswikiTable tr.foswikiTableRowdataBg1 td {background-color:#f7f7f6}
body .foswikiTable tr.foswikiTableRowdataBg1 td.foswikiSortedCol {background-color:#f0f0ee}
</style><!--TABLEPLUGIN_default-->
<script class="script JQUERYPLUGIN" src="../System/JQueryPlugin.attachments/jquery-2.2.4.js"></script><!--JQUERYPLUGIN-->
<script src="../System/JQueryPlugin.attachments/plugins/observer/observer.js?version=0.1" class="script JQUERYPLUGIN::OBSERVER"></script><!--JQUERYPLUGIN::OBSERVER-->
<script class="script JQUERYPLUGIN::MIGRATE" src="../System/JQueryPlugin.attachments/plugins/migrate/jquery.migrate.js?version=3.3.1"></script><!--JQUERYPLUGIN::MIGRATE-->
<script src="../System/JQueryPlugin.attachments/plugins/foswiki/jquery.foswiki.js?version=3.01" class="script JQUERYPLUGIN::FOSWIKI"></script><!--JQUERYPLUGIN::FOSWIKI-->
<script class="script JQUERYPLUGIN::BROWSER" src="../System/JQueryPlugin.attachments/plugins/browser/jquery.browser.js?version=0.1.0"></script><!--JQUERYPLUGIN::BROWSER-->
<script class='script JQUERYPLUGIN::FOSWIKI::PREFERENCES foswikiPreferences' type='text/json'>{
   "SERVERTIME" : "08 Feb 2023 - 15:50",
   "TOPIC" : "SampleBaseline",
   "USERSWEB" : "Main",
   "WIKIUSERNAME" : "Main.WikiAdmin",
   "USERNAME" : "WikiAdmin",
   "PUBURLPATH" : "/foswiki/pub",
   "NAMEFILTER" : "[\\\\\\s*?~^$@%`\"'&|<:;>\\[\\]#\\x00-\\x1f]",
   "SCRIPTURLPATHS" : {},
   "WEB" : "CTSpedia",
   "COOKIEREALM" : "",
   "PUBURL" : "http://biostat1478.dhcp.mc.vanderbilt.edu/foswiki/pub",
   "URLHOST" : "http://biostat1478.dhcp.mc.vanderbilt.edu",
   "SYSTEMWEB" : "System",
   "SCRIPTURL" : "http://biostat1478.dhcp.mc.vanderbilt.edu/foswiki/bin",
   "SCRIPTSUFFIX" : "",
   "SCRIPTURLPATH" : "/foswiki/bin",
   "SKIN" : "natedit,pattern",
   "WIKINAME" : "WikiAdmin"
}
</script><!--JQUERYPLUGIN::FOSWIKI::PREFERENCES-->
</head>
<body>
<h1 id="Case_45Control_Design_45_Sampling_at_Baseline">  Case-Control Design - Sampling at Baseline </h1>
 Special type of <a href="CaseControlStudy.html">case-control study</a>: <strong>Case cohort design</strong>
<p></p>
<strong><em>Lead Editor(s):</em></strong> Jeff Martin, MD
<p></p>
<div class="foswikiToc" id="foswikiTOC"> <ul>
<li> <a href="#Summary_of_Case_45Control_Sampling"> Summary of Case-Control Sampling </a>
</li> <li> <a href="#Definition_of_Sampling_for_Case_Cohort_Design"> Definition of Sampling for Case Cohort Design </a>
</li> <li> <a href="#Diagram_of_Random_Sampling_at_Baseline"> Diagram of Random Sampling at Baseline </a>
</li> <li> <a href="#Sampling_Controls_at_Baseline"> Sampling Controls at Baseline </a>
</li> <li> <a href="#Case_45Based_Estimate_of_Exposed_and_Unexposed"> Case-Based Estimate of Exposed and Unexposed </a>
</li> <li> <a href="#Advantages_of_Case_45Cohort_Design"> Advantages of Case-Cohort Design </a>
</li> <li> <a href="#How_OR_61_Risk_Ratio_in_a_Case_45Cohort_Design"> How OR = Risk Ratio in a Case-Cohort Design </a>
</li></ul> 
</div>
<p></p>
<h2 id="Summary_of_Case_45Control_Sampling">  Summary of Case-Control Sampling </h2>
<table class="foswikiTable" rules="none">
	<thead>
		<tr class="foswikiTableOdd foswikiTableRowdataBgSorted0 foswikiTableRowdataBg0">
			<th class="foswikiTableCol0 foswikiFirstCol"> <a title="Sort by this column" rel="nofollow" href="../PublishPlugin/publish.html">Design</a> </th>
			<th class="foswikiTableCol1"> <a title="Sort by this column" href="../PublishPlugin/publish.html" rel="nofollow">Sampling</a> </th>
			<th class="foswikiTableCol2 foswikiLastCol"> <a title="Sort by this column" rel="nofollow" href="../PublishPlugin/publish.html">Measure of Association</a> </th>
		</tr>
	</thead>
	<tbody>
		<tr class="foswikiTableEven foswikiTableRowdataBgSorted0 foswikiTableRowdataBg0">
			<td class="foswikiTableCol0 foswikiFirstCol"> Case-cohort </td>
			<td class="foswikiTableCol1"> Entire cohort at baseline </td>
			<td class="foswikiTableCol2 foswikiLastCol"> <a href="RiskRatio.html">risk ratio</a> </td>
		</tr>
		<tr class="foswikiTableOdd foswikiTableRowdataBgSorted1 foswikiTableRowdataBg1">
			<td class="foswikiTableCol0 foswikiFirstCol"> <a href="SampleIncidence.html">Incidence-density</a> </td>
			<td class="foswikiTableCol1"> Non-cases at time of diagnosis </td>
			<td class="foswikiTableCol2 foswikiLastCol"> <a href="RateRatio.html">rate ratio</a> </td>
		</tr>
		<tr class="foswikiTableEven foswikiTableRowdataBgSorted0 foswikiTableRowdataBg0">
			<td class="foswikiTableCol0 foswikiFirstCol foswikiLast"> <a href="SampleEnd.html">Prevalent Case Control</a> </td>
			<td class="foswikiTableCol1 foswikiLast"> Non-cases at single point in time </td>
			<td class="foswikiTableCol2 foswikiLastCol foswikiLast"> <a href="OddsTerm.html">odds ratio</a> </td>
		</tr>
	</tbody></table>
<p></p> <ul>
<li> <strong>A random sample of the cohort baseline</strong> = <strong>case-cohort design</strong>
</li></ul> 
<p></p> <ul>
<li> <strong>At time each case is diagnosed</strong> = <strong>incidence density sampling</strong>  <ul>
<li> (<a href="SampleIncidence.html">Sampling Controls - Incidence Density Sampling</a>)
</li></ul> 
</li></ul> 
<p></p> <ul>
<li> <strong>From persons without disease at the end of follow-up</strong> = <strong>prevalent controls design <br /> </strong>  <ul>
<li> <strong>(<a href="SampleEnd.html">Sampling Controls at Follow-up</a>)</strong>
</li></ul> 
</li></ul> 
<p></p>
<h2 id="Definition_of_Sampling_for_Case_Cohort_Design">  Definition of Sampling for Case Cohort Design </h2>
<p></p>
One way to sample <a href="StudyControl.html">controls</a> within a <a href="StudyCohort.html">cohort</a> is to take a <a href="SamplingTerm.html">random sample</a> of a cohort at baseline. <ul>
<li> This is called a <strong>Case-Cohort Design</strong>.
</li></ul> 
It is relatively new and has not been frequently used. It was first described by the statistician Ross Prentice in 1986.  <ul>
<li> It seems odd at first to realize that you will likely be sampling future cases as well as controls when you take a random sample of a cohort at its baseline.
</li> <li> This means that a subject may be included both as a <a href="StudyCase.html">case</a> and a <a href="StudyControl.html">control</a>.
</li> <li> But this is also true of <a href="SampleIncidence.html">incidence density sampling</a> since a subject selected as a control at one time point may later become a case.
</li></ul> 
<p></p>
<h2 id="Diagram_of_Random_Sampling_at_Baseline">  Diagram of Random Sampling at Baseline </h2>
<p></p>
As you can see in the diagram below, <a href="StudyControl.html">controls</a> are chosen at baseline from the <a href="StudyCohort.html">hypothetical cohort</a>.
<p></p>
<strong>Case-cohort: sample baseline of cohort</strong>
<blockquote>
<p></p>
<img width="35" src="SampleBaseline.attachments/0527_1_b_N.JPG" alt="0527_1_b_N.JPG" height="59"> is sampled randomly from baseline.
</blockquote>
<p></p>
<blockquote>
<p></p>
<img src="SampleBaseline.attachments/0218_diagram_base.JPG" height="192" alt="0218_diagram_base.JPG" width="246">
</blockquote>
<p></p>
The case-cohort design is distinguished by taking a <a href="SamplingTerm.html">random sample</a> of the <a href="StudyCohort.html">study cohort</a> at baseline. <ul>
<li> Since everyone is eligible to be in this sample and it is taken independently of <a href="PredictorVariable.html">exposure</a>,
</li> <li> The sample will give an <a href="BiasDefinition.html">unbiased</a> approximation of the ratio of number of persons exposed over number of persons not exposed.
</li></ul> 
All of the cases are included in the study (although also could be a random sample),  <ul>
<li> So in a case-cohort design unbiased estimates of both:  <ul>
<li> The ratio of exposed to unexposed cases in the original cohort and
</li> <li> The ratio of exposed to unexposed in the original cohort are obtained.
</li></ul> 
</li></ul> 
<h2 id="Sampling_Controls_at_Baseline">  Sampling Controls at Baseline </h2>
<p></p>
Most people think that the best way to sample <a href="StudyControl.html">controls</a> is to wait until the end of <a href="FollowUpTime.html">follow-up</a> so that the investigator can be sure they will not be <a href="StudyCase.html">cases</a>.
<p></p>
<strong>Becoming a case is an artifact of the follow-up period</strong> of the <a href="StudyCohort.html">cohort</a>. <ul>
<li> The investigator cannot know whether many of the controls will be diagnosed with the study <a href="OutcomeVariable.html">outcome</a> the day after the study ends.
</li> <li> This is made even clearer by the example of the <a href="CohortStudy.html">cohort study</a> that uses death as an outcome. Everyone is eventually a case.
</li></ul> 
When we are looking for (i.e., sampling) controls, we do not necessarily have to guarantee that these are subjects will never become cases. <strong>All that is needed is to be sure that they are not cases at the time of control sampling.</strong> <strong>CONTROL GROUP is a random sample of the cohort at baseline.</strong>
<p></p>
<h2 id="Case_45Based_Estimate_of_Exposed_and_Unexposed">  Case-Based Estimate of Exposed and Unexposed </h2>
 The case-cohort design begins with the <a href="StudyCase.html">cases</a>, so like other types of case-control sampling it is case-based.  <ul>
<li> It differs from the other approaches to sampling <a href="StudyControl.html">controls</a> by taking a sample of the <a href="StudyCohort.html">cohort</a>, or the study base, <strong>at time zero</strong>.
</li></ul> 
<hr />
<p></p>
This random sample of the baseline population will estimate the <strong>proportion exposed and unexposed</strong> in the entire study base. <ul>
<li> With that ratio, the <a href="RiskRatio.html">risk ratio</a> for the study base experience can be estimated without <a href="BiasDefinition.html">bias</a>.
</li></ul> 
<p></p>
<h2 id="Advantages_of_Case_45Cohort_Design">  Advantages of Case-Cohort Design </h2>
<p></p> <ul>
<li> The use of the <strong>same control group for more than one <a href="OutcomeVariable.html">outcome</a></strong> or for additional follow-up at time later than the current study. (Examining time-varying exposures can be a problem if only baseline data are available on the controls.)
</li></ul> 
<p></p> <ul>
<li> Data from a <strong>population-based survey</strong> (questionnaires, perhaps biological samples stored) and that population can be tracked for the <a href="StudyIncidence.html">incidence</a> of a disease outcome. An <a href="EgCaseBaselineNetherlands.html">example of large population-based</a> survey from the Netherlands looked at the relationship between bladder cancer and vitamins.
</li></ul> 
<p></p>
<hr />
 The case-control design becomes a good alternative to the other types of case-control sampling if:
<p></p> <ul>
<li> The study has a <a href="StudyBase.html">primary study base</a> which has <strong>baseline information or biological specimens</strong> on the persons who would be eligible for sampling.
</li></ul> 
<span id="EstimateRisk"></span>
<p></p>
<h2 id="How_OR_61_Risk_Ratio_in_a_Case_45Cohort_Design">  How OR = Risk Ratio in a Case-Cohort Design </h2>
<p></p>
The graphic below shows the notational framework of the <a href="StudyAnalysis2x2.html">2x2 table</a> to illustrate the properties of the <a href="OddsTerm.html">odds ratio</a>.
<p></p>
<strong>There is a:</strong> <ol>
<li> <strong>A <a href="StudyCohort.html">cohort</a> of exposed and unexposed <a href="StudyCase.html">cases</a> <br /></strong>
</li> <li> <strong>Estimate of the proportion of exposed and unexposed in the whole cohort (<a href="StudyControl.html">controls</a>)</strong>
</li></ol> 
<blockquote><img width="187" height="146" alt="0319_1cohort.JPG" src="SampleBaseline.attachments/0319_1cohort.JPG"></blockquote>  <ul>
<li> <strong>EXPOSURE ODDS IN CASES = a/c</strong>
</li></ul> 
<p></p> <ul>
<li> <strong>EXPOSURE ODDS IN CONTROLS = b/d</strong>
</li></ul> 
The critical point is that the controls in the case cohort design estimate the proportions exposed and unexposed in the whole cohort,  <ul>
<li> <strong>so cells b and d are unbiased estimates of N1 and N0.</strong>
</li></ul> 
When the odds ratio of exposure in the cases and controls is formed and the notation from a cohort is substituted for the cells in the 2x2 table, the resulting ratio is the same as the risk ratio.
<p></p>
The odds of exposure among those with disease is easily formed simply by taking: <ul>
<li> The ratio of the counts in the cells from the disease column, and
</li> <li> The ratio of the counts in the cells from those without disease.
</li> <li> <strong>The ratio of the two ratios is the odds ratio.</strong>
</li></ul> 
<blockquote><img height="94" alt="0527_1_all_risk.JPG" src="SampleBaseline.attachments/0527_1_all_risk.JPG" width="187"></blockquote>
<p></p>
<hr />
<p></p>
<strong><em><br /></em></strong>
<p></p>
<hr />
<p></p>
<hr />
<p></p>
</body>